Clinical Trials Browser

Phase 3 × Carcinoma, Intraductal, Noninfiltrating × Metformin × Clear all

NCT01905046 2025-04-13

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Phase 3 Active not recruiting

86 enrolled 10 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating